ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 255111 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 255111; 2) Community: the network communities that were significantly associated with the response to NSC 255111; 3) Molecule: the relationships between components within communities and NSC 255111; 4) MDR: the compounds that were significantly associated with the NSC 255111.

NSC Compound Enrichment Correlation
NSC 696073 Null 0.0186186224062458 0.13945639
NSC 699934 Null 0.0186186224062458 0.39903748
NSC 717468 Null 0.0186186224062458 0.35325491
NSC 733149 Null 0.0186186224062458 0.29046878
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0186186224062458 0.43198545
NSC 750050 Null 0.0186186224062458 0.30787928
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.0186186224062458 0.31347847
NSC 753661 methyl ester prodigiosene 0.0186186224062458 0.36113885
NSC 762346 Null 0.0186186224062458 0.36341886
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0186186224062458 0.10702329
Total:157  Current:93    [First] [Prev] [Next] [Last]